1. Loss of NAMPT in aging retinal pigment epithelium reduces NAD+ availability and promotes cellular senescence
   Ravirajsinh N. Jadeja et al, 2018, Aging CrossRef
2. Mitochondria in Diabetic Kidney Disease
   Amna Ayesha Ahmad et al, 2021, Cells CrossRef
3. Potential of Polyphenols to Restore SIRT1 and NAD+ Metabolism in Renal Disease
   Claudia Tovar-Palacio et al, 2022, Nutrients CrossRef
4. Nicotinamide Mononucleotide: A Promising Molecule for Therapy of Diverse Diseases by Targeting NAD+ Metabolism
   Weiqi Hong et al, 2020, Frontiers in Cell and Developmental Biology CrossRef
5. NAD+ Anabolism Disturbance Causes Glomerular Mesangial Cell Injury in Diabetic Nephropathy
   Xue Li et al, 2022, International Journal of Molecular Sciences CrossRef
6. Role of SIRT-1 as a Target for Treatment and Prevention of Diabetic Nephropathy: A Review
   Anita Kumari et al, 2023, Current Molecular Pharmacology CrossRef
7. NAD+ Homeostasis in Diabetic Kidney Disease
   Jing Xu et al, 2021, Frontiers in Medicine CrossRef
8. Aging and Diabetic Kidney Disease: Emerging Pathogenetic Mechanisms and Clinical Implications
   Yi Chen et al, 2024, Current Medicinal Chemistry CrossRef
9. SIRT1–SIRT7 in Diabetic Kidney Disease: Biological Functions and Molecular Mechanisms
   Wenxiu Qi et al, 2022, Frontiers in Endocrinology CrossRef
10. Balancing NAD+ deficits with nicotinamide riboside: therapeutic possibilities and limitations
    Angelique Cercillieux et al, 2022, Cellular and Molecular Life Sciences CrossRef